Nikolay Lunchenkov

• Ensured projects governance and coordination of resources for Global Fund and a British pharmaceutical company; allocated 400,000 USD among different activities aimed to strengthen national HIV/AIDS services in 7 countries in Eastern Europe and Central Asia. National partners successfully established several interventions with focus on HIV prevention.

• Supported the team with developing SIR and SEIR models for different pathogens (e.g., identify main parameters for a model). • Supported the senior epidemiologist with on-going tasks, collect and provide essential information on demand. Participating in a "data hunting" project across business units (e.g., epidemiological key characteristics or COVID-19 surveillance). • Performed analysis of the current epidemiological situation and provide risk assessment of outbreak scenarios in different countries.

• Provided consultancy for a project aimed at building competence of key stakeholders working within HIV Prevention and Treatment. • Led a working group of British and Russian medical experts to develop recommendations to build more efficient systems for substance-related harm reduction services. Following on, 20 of the 52 recommendations were chosen to go forward for consideration for implementation within services.

Provided care and treatment for people living with HIV in the Moscow region with annual coverage of more than 7,000 patients. Participated as a co-investigator in IV Phase clinical trial of integrase inhibitors in our clinic.